206 related articles for article (PubMed ID: 32688456)
1. Identification and validation of novel DNA methylation markers for early diagnosis of lung adenocarcinoma.
Li M; Zhang C; Zhou L; Li S; Cao YJ; Wang L; Xiang R; Shi Y; Piao Y
Mol Oncol; 2020 Nov; 14(11):2744-2758. PubMed ID: 32688456
[TBL] [Abstract][Full Text] [Related]
2. Identification of diagnostic DNA methylation biomarkers specific for early-stage lung adenocarcinoma.
Cai Q; Zhang P; He B; Zhao Z; Zhang Y; Peng X; Xie H; Wang X
Cancer Genet; 2020 Aug; 246-247():1-11. PubMed ID: 32805686
[TBL] [Abstract][Full Text] [Related]
3. DNA methylation biomarkers for the occurrence of lung adenocarcinoma from TCGA data mining.
Zhu XF; Zhu BS; Wu FM; Hu HB
J Cell Physiol; 2018 Oct; 233(10):6777-6784. PubMed ID: 29667778
[TBL] [Abstract][Full Text] [Related]
4. Creation of a Prognostic Risk Prediction Model for Lung Adenocarcinoma Based on Gene Expression, Methylation, and Clinical Characteristics.
Ke H; Wu Y; Wang R; Wu X
Med Sci Monit; 2020 Oct; 26():e925833. PubMed ID: 33021972
[TBL] [Abstract][Full Text] [Related]
5. Investigating and modeling the differential DNA methylation for early lung adenocarcinoma diagnosis.
Shi X; Feng T; Xu Y; Wu X; Shao Y; Liang Z
Biomark Med; 2022 Sep; 16(13):947-958. PubMed ID: 35950410
[No Abstract] [Full Text] [Related]
6. Differential
Lin S; Tian C; Li J; Liu B; Ma T; Chen K; Gong W; Wang JM; Huang J
Oncol Rep; 2021 May; 45(5):. PubMed ID: 33786615
[TBL] [Abstract][Full Text] [Related]
7. Screening of Methylation Gene Sites as Prognostic Signature in Lung Adenocarcinoma.
Dong M; Yang Z; Li X; Zhang Z; Yin A
Yonsei Med J; 2020 Dec; 61(12):1013-1023. PubMed ID: 33251775
[TBL] [Abstract][Full Text] [Related]
8. Identification of significant genes as prognostic markers and potential tumor suppressors in lung adenocarcinoma via bioinformatical analysis.
Lu M; Fan X; Liao W; Li Y; Ma L; Yuan M; Gu R; Wei Z; Wang C; Zhang H
BMC Cancer; 2021 May; 21(1):616. PubMed ID: 34039311
[TBL] [Abstract][Full Text] [Related]
9. Exploring and comparing of the gene expression and methylation differences between lung adenocarcinoma and squamous cell carcinoma.
Yang Y; Wang M; Liu B
J Cell Physiol; 2019 Apr; 234(4):4454-4459. PubMed ID: 30317601
[TBL] [Abstract][Full Text] [Related]
10. Multi-platform analysis of methylation-regulated genes in human lung adenocarcinoma.
Wang J; Yu XF; OUYang N; Luo QL; Zhao SY; Guan XF; Chen T; Li JX
J Toxicol Environ Health A; 2019; 82(1):37-45. PubMed ID: 30626254
[TBL] [Abstract][Full Text] [Related]
11. Comprehensive Analysis of DNA Methylation and Gene Expression Datasets Identified MMP9 and TWIST1 as Important Pathogenic Genes of Lung Adenocarcinoma.
Tian W; Li YS; Zhang JH; Li JJ; Gao JH
DNA Cell Biol; 2018 Apr; 37(4):336-346. PubMed ID: 29443542
[TBL] [Abstract][Full Text] [Related]
12. A panel of DNA methylation biomarkers for detection and improving diagnostic efficiency of lung cancer.
Wei B; Wu F; Xing W; Sun H; Yan C; Zhao C; Wang D; Chen X; Chen Y; Li M; Ma J
Sci Rep; 2021 Aug; 11(1):16782. PubMed ID: 34408226
[TBL] [Abstract][Full Text] [Related]
13. Identification and validation of candidate epigenetic biomarkers in lung adenocarcinoma.
Daugaard I; Dominguez D; Kjeldsen TE; Kristensen LS; Hager H; Wojdacz TK; Hansen LL
Sci Rep; 2016 Oct; 6():35807. PubMed ID: 27782156
[TBL] [Abstract][Full Text] [Related]
14. Genomewide DNA methylation analysis identifies novel methylated genes in non-small-cell lung carcinomas.
Carvalho RH; Hou J; Haberle V; Aerts J; Grosveld F; Lenhard B; Philipsen S
J Thorac Oncol; 2013 May; 8(5):562-73. PubMed ID: 23524404
[TBL] [Abstract][Full Text] [Related]
15.
Goto D; Komeda K; Uwatoko N; Nakashima M; Koike M; Kawai K; Kodama Y; Miyazawa A; Tanaka I; Hase T; Morise M; Hasegawa Y; Kawabe T; Sato M
Cancer Invest; 2020 Apr; 38(4):240-249. PubMed ID: 32212938
[TBL] [Abstract][Full Text] [Related]
16. DNA methylation patterns at and beyond the histological margin of early-stage invasive lung adenocarcinoma radiologically manifested as pure ground-glass opacity.
Jia Z; Wang Y; Xue J; Yang X; Bing Z; Guo C; Gao C; Tian Z; Zhang Z; Kong H; He Q; Su Z; Liu Y; Song Y; Liang D; Liang N; Li S; Gao Y
Clin Epigenetics; 2021 Aug; 13(1):153. PubMed ID: 34407868
[TBL] [Abstract][Full Text] [Related]
17. Data mining-based identification of epigenetic signatures with discrimination potential of lung adenocarcinoma and squamous cell carcinoma.
Pang WG; Ye M; Chen JR; Zhang L; Wang Z
Mol Biol Rep; 2024 Feb; 51(1):255. PubMed ID: 38302782
[TBL] [Abstract][Full Text] [Related]
18. A functional methylation signature to predict the prognosis of Chinese lung adenocarcinoma based on TCGA.
Wang K; Liu Y; Lu G; Xiao J; Huang J; Lei L; Peng J; Li Y; Wei S
Cancer Med; 2022 Jan; 11(1):281-294. PubMed ID: 34854250
[TBL] [Abstract][Full Text] [Related]
19. Low expression of ITIH5 in adenocarcinoma of the lung is associated with unfavorable patients' outcome.
Dötsch MM; Kloten V; Schlensog M; Heide T; Braunschweig T; Veeck J; Petersen I; Knüchel R; Dahl E
Epigenetics; 2015; 10(10):903-12. PubMed ID: 26252352
[TBL] [Abstract][Full Text] [Related]
20. Integrated analysis of miRNAs and DNA methylation identifies miR-132-3p as a tumor suppressor in lung adenocarcinoma.
Su Y; Shetty A; Jiang F
Thorac Cancer; 2020 Aug; 11(8):2112-2124. PubMed ID: 32500672
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
